C
Christoph Liebetrau
Researcher at University of Giessen
Publications - 274
Citations - 7915
Christoph Liebetrau is an academic researcher from University of Giessen. The author has contributed to research in topics: Myocardial infarction & Acute coronary syndrome. The author has an hindex of 36, co-authored 249 publications receiving 5940 citations. Previous affiliations of Christoph Liebetrau include Technische Universität München & Leipzig University.
Papers
More filters
Journal ArticleDOI
Circulating MicroRNAs in Patients With Coronary Artery Disease
Stephan Fichtlscherer,Salvatore De Rosa,Henrik Fox,Thomas Schwietz,Ariane Fischer,Christoph Liebetrau,Michael Weber,Christian W. Hamm,Tino Röxe,Marga Muller-Ardogan,Angelika Bonauer,Andreas M. Zeiher,Stefanie Dimmeler +12 more
TL;DR: Circulating levels of vascular and inflammation-associated microRNAs are significantly downregulated in patients with coronary artery disease.
Journal ArticleDOI
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Stefanie Schüpke,Franz-Josef Neumann,Maurizio Menichelli,Katharina Mayer,Isabell Bernlochner,Jochen Wöhrle,Gert Richardt,Christoph Liebetrau,Bernhard Witzenbichler,David Antoniucci,Ibrahim Akin,Lorenz Bott-Flügel,Marcus Fischer,Ulf Landmesser,Hugo A. Katus,Dirk Sibbing,Melchior Seyfarth,Marion Janisch,Duino Boncompagni,Raphaela Hilz,Wolfgang Rottbauer,Rainer Okrojek,Helge Möllmann,Willibald Hochholzer,Angela Migliorini,Salvatore Cassese,Pasquale Mollo,Erion Xhepa,Sebastian Kufner,Axel Strehle,Stefan Leggewie,Abdelhakim Allali,Gjin Ndrepepa,Helmut Schühlen,Dominick Angiolillo,Christian W. Hamm,Alexander Hapfelmeier,Ralph Tölg,Dietmar Trenk,Heribert Schunkert,Karl-Ludwig Laugwitz,Adnan Kastrati +41 more
TL;DR: Among patients who presented with acute coronary syndromes with or without ST-segment elevation, the incidence of death, myocardial infarction, or stroke was significantly lower among those who received prasugrel than amongThose who received ticagrelor, and the probability of major bleeding was not significantly different between the two groups.
Journal ArticleDOI
Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
Enno Boudriot,Holger Thiele,Thomas Walther,Christoph Liebetrau,Peter Boeckstegers,Tilmann Pohl,Bruno Reichart,Harald Mudra,Florian Beier,Brigitte Gansera,Franz-Josef Neumann,Michael Gick,Thomas Zietak,Steffen Desch,Gerhard Schuler,Friedrich-Wilhelm Mohr +15 more
TL;DR: In patients with ULM stenosis, PCI with sirolimus-eluting stents did not show noninferiority to CABG at 12-month follow-up with respect to freedom from major adverse cardiac events, which is mainly influenced by repeated revascularization, whereas for hard endpoints, [corrected] PCI results are favorable.
Journal ArticleDOI
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx,Marco Valgimigli,Peter Jüni,Christian W. Hamm,Philippe Gabriel Steg,Philippe Gabriel Steg,Dik Heg,Gerrit Anne van Es,Eùgene P. McFadden,Yoshinobu Onuma,Cokky van Meijeren,Ply Chichareon,Edouard Benit,Helge Möllmann,Luc Janssens,Maurizio Ferrario,Aris Moschovitis,Aleksander Zurakowski,Marcello Dominici,Robert-Jan van Geuns,Kurt Huber,Ton Slagboom,Patrick W. Serruys,Patrick W. Serruys,Stephan Windecker,Mohamed Abdellaoui,David Adlam,Ibrahim Akin,Agustin Albarran Gonzalez-Trevilla,Manuel de Sousa Almeida,Pedro Alves Lemos Neto,Adel Aminian,Richard A. Anderson,Rick Andreae,Michael Angioi,Taku Asano,Emanuele Barbato,Peter Barlis,Pascal Barraud,Olivier F. Bertrand,Farzin Beygui,Leonardo Bolognese,Roberto Botelho,Coby Bouwman,Marco Bressers,Philippe Brunel,Paweł Buszman,Ian Buysschaert,Pedro Canas da Silva,Didier Carrié,Angel Cequier,Chun Chin Chang,Saqib Chowdhary,Carlos Collet,Antonio Colombo,James Cotton,Rui Cruz Ferreira,Salvatore Curello,Nick Curzen,Judith de Bot,Tone de Vreede,Georg Delle Karth,Lynn Dijksma,István Édes,Eric Eeckhout,Ingo Eitel,József Faluközy,Farzin Fath-Ordoubadi,Géza Fontos,Jose Francisco Diaz,Edgard Freitas Quintella,Bernhard Frey,Guy Friedrich,Gavin Galasko,Grzegorz Galuszka,Vasco Gama Ribeiro,Scot Garg,Giuseppe Gargiulo,Tobias Geisler,Valeri Gelev,Art Ghandilyan,Javier Goicolea,Tommaso Gori,Felice Gragnano,Ana H.C. Guimarães,Michael Haude,Pieter Heijke,Rosa Ana Hernández Antolin,David Hildick-Smith,Dorien Hillen,Ina Hoekman,Sjoerd H. Hofma,Lene Holmvang,Stephen P. Hoole,Iván Horváth,Annemarie Hugense,Karim Ibrahim,Andrés Iñiguez,Karl Isaaz,Zoltan Jambrik,Pawel Jasionowicz,Judith Jonk,Werner Jung,Yuki Katagiri,Norihiro Kogame,Tian Hai Koh,René Koning,Mariana Konteva,Zsolt Kőszegi,Florian Krackhardt,Yvonne Kreuger,Neville Kukreja,Boudijn Ladan,Pierre Lantelme,Sergio Leandro,Gregor Leibundgut,Christoph Liebetrau,Wietze Lindeboom,Carlos Macaya Miguel,François Mach,Michael Magro,Luc Maillard,Negar Manavifar,Laura Mauri,Eugene P. McFadden,Béla Merkely,Yosuke Miyazaki,Adam Młodziankowski,Tiziano Moccetti,Rodrigo Modolo,Helge Möllman,Jean-François Morelle,Michael Munndt Ottesen,Martin Muurling,Christoph Naber,Franz-Josef Neumann,Keith G. Oldroyd,Paul J.L. Ong,Sanne Palsrok,Ivo Petrov,Sylvain Plante,Janusz Prokopczuk,Tessa Rademaker-Havinga,Christopher Raffel,Benno J. Rensing,Marco Roffi,Kees-Jan Royaards,Manel Sabaté,Volker Schächinger,Tim Seidler,Antonio Serra Peñaranda,Patrick W. Serruys,Lali Sikarulidze,Osama Ibrahim Ibrahim Soliman,Amanda Sousa,Ernest Spitzer,Rod Stables,Gabriel Steg,Clemens Steinwender,Eduardas Subkovas,Harry Suryapranata,Kuniaki Takahashi,Suneel Talwar,Emmanuel Teiger,Addy ter Weele,Eva Teurlings,Attila Thury,Jan Tijssen,Gincho Tonev,Diana Trendafilova-Lazarova,Carlo Tumscitz,Victor A. Umans,Imre Ungi,Veselin Valkov,Pim van der Harst,Dobrin Vassilev,Vasil Velchev,Esther Velthuizen,Freek W.A. Verheugt,Natalia Vlcek,Jürgen vom Dahl,Mathias Vrolix,Simon J Walsh,Nikos Werner,Maarten Witsenburg,Azfar Zaman,Krzysztof Żmudka,Bernhard Zrenner,Robert Zweiker +188 more
TL;DR: The GLOBAL LEADERS trial as discussed by the authors showed that ticagrelor, in combination with aspirin for 1 month, followed by ticaragrelor alone, improves outcomes after percutaneous coronary intervention compared with standard antiplatelet regimens.
Journal ArticleDOI
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
Johannes T Neumann,Raphael Twerenbold,Francisco Ojeda,Nils A Sörensen,Andrew R. Chapman,Anoop S V Shah,Atul Anand,Jasper Boeddinghaus,Thomas Nestelberger,Patrick Badertscher,Arash Mokhtari,John W. Pickering,Richard W. Troughton,Jaimi H. Greenslade,William A. Parsonage,Matthias Mueller-Hennessen,Tommaso Gori,Tomas Jernberg,Niall Morris,Christoph Liebetrau,Christian W. Hamm,Hugo A. Katus,Thomas Münzel,Ulf Landmesser,Veikko Salomaa,Licia Iacoviello,Marco M Ferrario,Simona Giampaoli,Frank Kee,Barbara Thorand,Annette Peters,Rossana Borchini,Torben Jørgensen,Torben Jørgensen,Stefan Söderberg,Susana Sans,Hugh Tunstall-Pedoe,Kari Kuulasmaa,Thomas Renné,Karl J. Lackner,Andrew Worster,Richard Body,Ulf Ekelund,Peter A. Kavsak,Till Keller,Bertil Lindahl,Philipp S. Wild,Evangelos Giannitsis,Martin Than,Louise Cullen,Nicholas L. Mills,Christian Mueller,Tanja Zeller,Dirk Westermann,Stefan Blankenberg +54 more
TL;DR: In this article, high-sensitivity troponin concentrations in patients presenting to the emergency department with symptoms suggestive of myocardial infarction may be useful in determining t...